Mechanistically, cancer-FOXP3 directly transactivates CCL5, and the CCL5-CCR5 axis promotes Treg cell accumulation in tumor lesions from peripheral blood in vitro and in vivo (106). This evidence concerns the gene CCL5 and neoplasm.